SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-022071
Filing Date
2023-03-22
Accepted
2023-03-22 16:06:13
Documents
68
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_virpaxpharm.htm   iXBRL 10-K 1413745
2 DESCRIPTION OF SECURITIES f10k2022ex4-4_virpaxpharma.htm EX-4.4 25332
3 CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR TH f10k2022ex23-1_virpaxpharm.htm EX-23.1 2270
4 CERTIFICATION f10k2022ex31-1_virpaxpharma.htm EX-31.1 10795
5 CERTIFICATION f10k2022ex31-2_virpaxpharma.htm EX-31.2 10920
6 CERTIFICATION f10k2022ex32-1_virpaxpharma.htm EX-32.1 6024
7 GRAPHIC img_001.jpg GRAPHIC 66427
8 GRAPHIC img_002.jpg GRAPHIC 64570
9 GRAPHIC img_003.jpg GRAPHIC 142007
10 GRAPHIC img_004.jpg GRAPHIC 61082
11 GRAPHIC img_005.jpg GRAPHIC 34857
12 GRAPHIC img_006.jpg GRAPHIC 55635
13 GRAPHIC img_007.jpg GRAPHIC 156145
14 GRAPHIC img_008.jpg GRAPHIC 118204
15 GRAPHIC img_009.jpg GRAPHIC 66641
  Complete submission text file 0001213900-23-022071.txt   6630750

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE vrpx-20221231.xsd EX-101.SCH 41862
17 XBRL CALCULATION FILE vrpx-20221231_cal.xml EX-101.CAL 18123
18 XBRL DEFINITION FILE vrpx-20221231_def.xml EX-101.DEF 181785
19 XBRL LABEL FILE vrpx-20221231_lab.xml EX-101.LAB 385423
20 XBRL PRESENTATION FILE vrpx-20221231_pre.xml EX-101.PRE 196663
62 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_virpaxpharm_htm.xml XML 304888
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40064 | Film No.: 23752964
SIC: 2834 Pharmaceutical Preparations